SPC25 promotes hepatocellular carcinoma metastasis via activating the FAK/PI3K/AKT signaling pathway through ITGB4-Reference-Cited by-同舟云学术

SPC25 promotes hepatocellular carcinoma metastasis via activating the FAK/PI3K/AKT signaling pathway through ITGB4

Published:2022-03-15 Issue:5 Volume:47 Page:
ISSN:1021-335X
Container-title:Oncology Reports
language:
Short-container-title:Oncol Rep

Author:

Shi Wen-Kai¹,Shang Qiao-Li²,Zhao Yong-Fu¹

Affiliation:

1. Department of Hepatopancreatobiliary Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, P.R. China

2. The Seventh Plastic Department, Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100144, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,General Medicine

Reference38 articles.

1. Lenvatinib plus EGFR inhibition for liver cancer;Hindson;Nat Rev Gastroenterol Hepatol,2021

2. Hepatocellular carcinoma;Villanueva;N Engl J Med,2019

3. SHARP investigators study group: Sorafenib in advanced hepatocellular carcinoma;Llovet;N Engl J Med,2008

4. Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: A randomised phase 3 non-inferiority trial;Kudo;Lancet,2018

5. Insights into the success and failure of systemic therapy for hepatocellular carcinoma;Bruix;Nat Rev Gastroenterol Hepatol,2019

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The mechanism of ITGB4 in tumor migration and invasion;Frontiers in Oncology;2024-08-07

2. NEDD4L mediates ITGB4 ubiquitination and degradation to suppress esophageal carcinoma progression;Cell Communication and Signaling;2024-06-03

3. ING3 inhibits the malignant progression of lung adenocarcinoma by negatively regulating ITGB4 expression to inactivate Src/FAK signaling;Cellular Signalling;2024-05

4. SPC25 Functions as a Prognostic-Related Biomarker, and Its High Expression Correlates with Tumor Immune Infiltration and UCEC Progression;Frontiers in Bioscience-Landmark;2024-02-20

5. SPC25 as a novel therapeutic and prognostic biomarker and its association with glycolysis, ferroptosis and ceRNA in lung adenocarcinoma;Aging;2024-01-11